The body endogenously produces all the cholesterol necessary for vital functions. Optimal LDL levels are around 40 mg/dL, similar to a newborn's. Higher levels, typically from diet, are not needed and function like a toxin, initiating atherosclerosis.

Related Insights

Beyond creating Vitamin D, sunlight has a direct cardiovascular benefit. UV light triggers the conversion of nitrogen compounds in the skin into nitric oxide. This molecule enters the bloodstream, causing arteries to relax and subsequently lowering blood pressure, providing a clear biochemical mechanism for sunlight's association with lower mortality rates.

HDL cholesterol, typically seen as protective, can become dysfunctional in the presence of risk factors like smoking or obesity. This dysfunctional HDL then contributes to atherosclerosis instead of preventing it, challenging the simplistic 'good vs. bad' cholesterol narrative.

Many chronic illnesses, including high blood pressure, cancer, and cognitive decline, are not separate issues but symptoms of a single underlying problem: chronically elevated insulin levels. This metabolic “trash” accumulates over years, making the body a breeding ground for disease.

The fitness trend of consuming very high amounts of protein (e.g., 1g per pound of body weight) is not supported by data. Amounts exceeding 1 gram per kilogram, especially from animal sources, can lead to systemic inflammation and promote the development of atherosclerosis (clogged arteries).

The vascular damage from sugar is direct and chemical. Excess glucose acts like glue, binding to and disabling the very enzymes that produce nitric oxide. This shuts down the body's ability to dilate blood vessels, leading to a cascade of health issues like hypertension and peripheral neuropathy.

While many aim for the highest possible ketone readings, research indicates the therapeutic 'sweet spot' is 1-2 millimolar for most applications. Levels above this can cause 'reductive stress' and energy toxicity, which are counterproductive for general metabolic health.

Focusing solely on LDL is a mistake. Even individuals with a genetic mutation leading to lifelong low LDL levels can still have cardiovascular events if they have other unmanaged risk factors like metabolic syndrome, obesity, or diabetes, highlighting the need for a comprehensive approach.

The silent nature of high cholesterol creates a psychological barrier. Patients who feel perfectly healthy are often unwilling to commit to lifelong treatment, even when their risk is high, leading to preventable cardiovascular events.

Universal cholesterol screening in young children acts as a trigger for cascade screening, where parents (often in their 30s) and grandparents (50s) are also tested. This uncovers and allows for treatment of familial hypercholesterolemia across three generations from a single pediatric test.

The development of PCSK9 inhibitors, a powerful class of cholesterol-lowering drugs, originated not from studying disease but from studying healthy people with a genetic mutation causing exceptionally low LDL. This highlights the value of investigating positive outliers in human biology.